Quality of life by smoking status in patients with metastatic or advanced NSCLC from Phase 2 clinical trial of veliparib with carboplatin and paclitaxel

Authors :: Mark D. McKee
Annie Guerin
Martin Cloutier
Q. Qin
Jane Qian
Fan Mu
Eric Q. Wu
Marjolaine Gauthier-Loiselle
Patrick Bonnet
Vincent L. Giranda
Source :: Journal of Clinical Oncology. 34:e20549-e20549
Publication Year :: 2016
Publisher :: American Society of Clinical Oncology (ASCO), 2016.
Abstract: e20549Background: A Phase 2 clinical trial of veliparib + carboplatin (C) and paclitaxel (P) in patients (pts) with previously untreated metastatic/advanced NSCLC showed that veliparib may improve ...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Veliparib
business.industry
Phases of clinical research
Carboplatin
chemistry.chemical_compound
chemistry
Paclitaxel
Quality of life
Internal medicine
medicine
In patient
Smoking status
business
neoplasms

Full Text Access

Tools